DelveInsight's "Chronic Pain - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Chronic Pain epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
The DelveInsight Chronic Pain epidemiology report gives a thorough understanding of the Chronic Pain by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Chronic Pain in the US, Europe, and Japan. The report covers the detailed information of the Chronic Pain epidemiology scenario in seven major countries (US, EU5, and Japan).
The Chronic Pain epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Chronic Pain epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Chronic Pain epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
The Chronic Pain epidemiology covered in the report provides historical as well as forecasted Chronic Pain epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
The DelveInsight Chronic Pain report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
The Chronic Pain Epidemiology report will allow the user to -
1. Key Insights
2. Executive Summary of Chronic Pain
3. Chronic Pain: Disease Background and Overview
3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis
4. Patient Journey
5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
5.3.1. Chronic Pain Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
5.4.1. Chronic Pain Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
5.5.1. Germany Epidemiology
5.5.1.1. Chronic Pain Epidemiology Scenario in Germany (2019- 2032)
5.5.2. France Epidemiology
5.5.2.1. Chronic Pain Epidemiology Scenario in France (2019- 2032)
5.5.3. Italy Epidemiology
5.5.3.1. Chronic Pain Epidemiology Scenario in Italy (2019- 2032)
5.5.4. Spain Epidemiology
5.5.4.1. Chronic Pain Epidemiology Scenario in Spain (2019- 2032)
5.5.5. United Kingdom Epidemiology
5.5.5.1. Chronic Pain Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
5.6.1. Chronic Pain Epidemiology Scenario in Japan (2019- 2032)
6. Treatment Algorithm, Current Treatment, and Medical Practices
6.1. Chronic Pain Treatment and Management
6.2. Chronic Pain Treatment Algorithm
7. KOL Views
8. Unmet Needs
9. Appendix
9.1. Bibliography
9.2. Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
*The table of contents is not exhaustive; will be provided in the final report
List of Tables
Table 1: Chronic Pain Epidemiology in 7MM (2019-2032)
Table 2: Chronic Pain Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Chronic Pain Epidemiology in the United States (2019-2032)
Table 4: Chronic Pain Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Chronic Pain Epidemiology in Germany (2019-2032)
Table 6: Chronic Pain Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Chronic Pain Epidemiology in France (2019-2032)
Table 8: Chronic Pain Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Chronic Pain Epidemiology in Italy (2019-2032)
Table 10: Chronic Pain Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Chronic Pain Epidemiology in Spain (2019-2032)
Table 12: Chronic Pain Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Chronic Pain Epidemiology in the United Kingdom (2019-2032)
Table 14: Chronic Pain Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Chronic Pain Epidemiology in Japan (2019-2032)
Table 16: Chronic Pain Diagnosed and Treatable Cases in Japan (2019-2032)
List of Figures
Figure 1 Chronic Pain Epidemiology in 7MM (2019-2032)
Figure 2 Chronic Pain Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Chronic Pain Epidemiology in the United States (2019-2032)
Figure 4 Chronic Pain Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Chronic Pain Epidemiology in Germany (2019-2032)
Figure 6 Chronic Pain Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Chronic Pain Epidemiology in France (2019-2032)
Figure 8 Chronic Pain Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Chronic Pain Epidemiology in Italy (2019-2032)
Figure 10 Chronic Pain Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Chronic Pain Epidemiology in Spain (2019-2032)
Figure 12 Chronic Pain Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Chronic Pain Epidemiology in the United Kingdom (2019-2032)
Figure 14 Chronic Pain Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Chronic Pain Epidemiology in Japan (2019-2032)
Figure 16 Chronic Pain Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report
